Lucas Ward
Stock Analyst at Ascendiant Capital
(0.85)
# 3,969
Out of 5,090 analysts
25
Total ratings
36%
Success rate
-29.68%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $2.13 | +158.22% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $3 → $2.8 | $1.00 | +180.00% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $6.91 | +232.85% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $2.00 | +110.00% | 6 | Nov 20, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $2.57 | +250.19% | 3 | Oct 1, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $1.02 | +264,605.88% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $2.13
Upside: +158.22%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $3 → $2.8
Current: $1.00
Upside: +180.00%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $6.91
Upside: +232.85%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $2.00
Upside: +110.00%
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $2.57
Upside: +250.19%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $1.02
Upside: +264,605.88%